Featured Funds

High-beta innovation bets that swing hard with tech narratives and macro tides.

Last 13F: 09/30/25

The slow-moving capital star that quietly owns chunks of the real economy while everyone else chases charts.

Last 13F: 09/30/25

The world's largest hedge fund, running systematic macro and risk-parity playbooks at massive scale.

Last 13F: 09/30/25

Steve Cohen's rebuilt empire, mixing pods and discretionary stock picking under a microscope of risk control.

Last 13F: 09/30/25

A ruthless talent farm running multi-manager pods with a strong 'adapt or vanish' culture.

Last 13F: 09/30/25

An ex-Millennium offspring built as a sprawling macro and fixed-income pod kingdom.

Last 13F: 09/30/25

Event-driven and distressed specialists quietly harvesting mispricings around big corporate inflection points.

Last 13F: 09/30/25

Seth Klarman's fortress of deep value and special situations, happiest when everyone else is panicking.

Last 13F: 09/30/25

A quant cathedral where PhDs, data, and GPUs collaborate to grind tiny edges into huge capital.

Last 13F: 09/30/25

The factor-priesthood of Wall Street, turning academic finance papers into real-world, sometimes painful, P&L.

Last 13F: 09/30/25

An ultra-secretive, math-obsessed quant shop born inside Morgan Stanley that now runs its own black-box universe.

Last 13F: 09/30/25

A multi-strat platform leaning into quant and equity market-neutral, constantly rebalancing its stable of pods.

Last 13F: 09/30/25

A centuries-old British trading house reborn as a global quant and alternatives behemoth.

Last 13F: 09/30/25

Momentum-fueled growth and VC blitzkrieg, famous for riding tech booms hard and wearing the crashes.

Last 13F: 09/30/25

A Tiger Cub obsessed with tech and internet names, toggling between public growth bets and private unicorn hunting.

Last 13F: 09/30/25

Quiet, deadly fundamental stock pickers with Tiger DNA and a taste for concentrated convictions.

Last 13F: 09/30/25

A high-conviction, fundamentally driven long/short fund that treats great companies like long-term trophies.

Last 13F: 09/30/25

Bill Ackman's concentrated activist vehicle built around a few huge, very public conviction bets.

Last 13F: 09/30/25

Dan Loeb's opportunistic hedge fund mixing activist agitation with sharp, event-driven trades.

Last 13F: 09/30/25

David Tepper's macro-and-distressed war machine, happiest when markets are in full-blown chaos.

Last 13F: 09/30/25

A global-macro classic, famous for asymmetric currency and rates bets that can shake entire countries.

Last 13F: 09/30/25

A ruthlessly fundamental long-only activist platform laser-focused on moaty compounders and boardroom pressure.

Last 13F: 09/30/25

A healthcare-heavy fundamental shop that loves complex stories where the Street is still half-asleep.

Last 13F: 09/30/25

A Tiger-cub descendant running concentrated, research-heavy long/short books around secular themes.

Last 13F: 09/30/25

A quiet multi-strategy powerhouse roaming credit, event-driven, and private deals in search of mispriced risk.

Last 13F: 09/30/25

The firm that defined the 'big short' and now hunts event-driven and special-situations value across cycles.

Last 13F: 09/30/25

An old-school institutional giant steering pension and sovereign money through every asset class on earth.

Last 13F: 09/30/25

An ultra-patient, low-turnover value house treating every position like a long-term partnership stake.

Last 13F: 09/30/25

Howard Marks' temple of credit and distressed, built on patience, discipline, and memos the whole Street reads.

Last 13F: 09/30/25

A factor-investing purist turning academic finance into low-cost, rules-based portfolios used worldwide.

Last 13F: 09/30/25

A multi-strategy platform running systematic and discretionary pods across equities, credit, and macro.

Last 13F: 09/30/25

An event-driven and multi-manager specialist navigating M&A arbitrage, special situations, and equity hedging.

Last 13F: 09/30/25

A multi-strategy platform running quantitative and discretionary pods across equities and macro.

Last 13F: 09/30/25

A diversified alternative asset manager blending credit, real estate, and equity strategies across global markets.

Last 13F: 09/30/25

A systematic and discretionary multi-strategy fund blending quantitative signals with fundamental overlays.

Last 13F: 09/30/25

A technology-focused long/short fund with a growth bias and concentrated conviction portfolio.

Last 13F: 09/30/25

A concentrated fundamental investor focusing on technology and consumer growth themes with deep research.

Last 13F: 09/30/25

A fundamental long/short fund with a focus on technology and consumer growth themes.

Last 13F: 09/30/25

A macro hedge fund deploying systematic and discretionary strategies across rates, FX, commodities, and equity indices.

Last 13F: 09/30/25

A fundamental long/short fund with a focus on bottom-up stock picking and differentiated research.

Last 13F: 09/30/25

A long/short equity fund with a technology bias, running concentrated portfolios in growth and innovation themes.

Last 13F: 09/30/25

A global macro and emerging markets specialist hunting structural shifts and secular trends across geographies.

Last 13F: 09/30/25

A concentrated long-only investor focusing on Asian growth equities and secular winners.

Last 13F: 09/30/25

A D.E. Shaw affiliate running systematic and discretionary strategies with a focus on quantitative research.

Last 13F: 09/30/25

A growth-focused long/short fund hunting secular winners in technology, internet, and consumer sectors.

Last 13F: 09/30/25

A growth equity specialist bridging public and private markets, focusing on high-growth technology companies.

Last 13F: 09/30/25

A tech-focused growth investor running concentrated public and private portfolios in secular innovation themes.

Last 13F: 09/30/25

A venture-style public equity investor focusing on early-stage growth companies and disruptive technology themes.

Last 13F: 09/30/25

A fundamental long/short fund with a focus on technology, media, and telecommunications sectors.

Last 13F: 09/30/25

A concentrated fundamental investor focusing on high-quality compounders and differentiated research insights.

Last 13F: 09/30/25

A global equity manager focusing on quality growth companies with sustainable competitive advantages.

Last 13F: 09/30/25

A growth equity specialist seeking businesses with durable competitive advantages and long-term compounding potential.

Last 13F: 09/30/25

A concentrated fundamental investor focusing on high-quality compounders with sustainable competitive advantages.

Last 13F: 09/30/25

An active growth equity manager focusing on large-cap quality compounders and dividend growers.

Last 13F: 09/30/25

Jim Simons' legendary quant firm running the RIEF fund with systematic strategies across global equities.

Last 13F: 09/30/25

A technology-focused growth investor running concentrated public and private portfolios in secular winners.

Last 13F: 09/30/25

A healthcare giant investing across biotech, pharmaceuticals, and medical devices with global reach.

Last 13F: 09/30/25

A healthcare-focused fund investing across the biotech lifecycle, from venture to public equities.

Last 13F: 09/30/25

A healthcare specialist blending venture capital with public equity investing in biotech and life sciences.

Last 13F: 09/30/25

A healthcare specialist focusing on life sciences, biotech, and pharmaceutical investments across public and private markets.

Last 13F: 09/30/25

A biotech specialist with deep scientific expertise, focusing on clinical-stage and commercial life sciences companies.

Last 13F: 09/30/25

A healthcare fund blending fundamental research with event-driven catalyst plays in biotech and pharmaceuticals.

Last 13F: 09/30/25

A healthcare-focused activist investor targeting operational improvements and strategic value creation in biotech.

Last 13F: 09/30/25

A long-biased equity fund with a growth tilt, running concentrated portfolios in quality compounders.

Last 13F: 09/30/25

An aggressive activist shop known for proxy fights, board overhauls, and relentless pressure on underperforming management teams.

Last 13F: 09/30/25

A multi-strategy juggernaut blending activist campaigns, distressed credit, and global macro with ruthless efficiency.

Last 13F: 09/30/25

An activist boutique that sharpens its focus on operational underperformers and quietly forces companies into value-unlocking transformations.

Last 13F: 09/30/25

An activist investor targeting small and mid-cap companies with operational improvement opportunities.

Last 13F: 09/30/25

A collaborative activist firm working with management teams to unlock value through operational improvements.

Last 13F: 09/30/25

A value-oriented investment manager focusing on dividend-paying stocks and disciplined capital allocation.

Last 13F: 09/30/25

A concentrated growth equity manager running low-turnover portfolios in quality compounders with long-term horizons.

Last 13F: 09/30/25

A fundamental equity manager running global growth portfolios with deep research and patient capital.

Last 13F: 09/30/25

A global equity manager focusing on quality growth businesses with sustainable competitive advantages.

Last 13F: 09/30/25

A boutique asset manager running concentrated, high-conviction portfolios across growth and value strategies.

Last 13F: 09/30/25

A concentrated growth equity manager seeking businesses with durable competitive advantages and pricing power.

Last 13F: 09/30/25

A quality-focused growth investor running concentrated portfolios in businesses with compounding potential and strong management.

Last 13F: 09/30/25

A value-oriented investor seeking mispriced businesses with strong fundamentals and long-term intrinsic value growth.

Last 13F: 09/30/25

A boutique manager running concentrated portfolios with a focus on special situations and fundamental research.

Last 13F: 09/30/25

A fundamental long/short fund with a focus on event-driven opportunities and catalyst-rich situations.

Last 13F: 09/30/25

An activist platform focused on ESG-driven value creation and strategic transformations in energy and industrial sectors.

Last 13F: 09/30/25

A fundamental long/short fund running concentrated portfolios with deep research and patient capital.

Last 13F: 09/30/25

A fundamental activist investor focusing on operational improvements and strategic alternatives in mid-cap companies.

Last 13F: 09/30/25

An event-driven and credit specialist hunting mispricings in distressed situations and corporate restructurings.

Last 13F: 09/30/25

A systematic macro and volatility fund deploying quantitative models across global markets.

Last 13F: 09/30/25

An event-driven specialist navigating M&A arbitrage, special situations, and activist campaigns.

Last 13F: 09/30/25

A global technology investor bridging public and private markets with a focus on secular growth themes.

Last 13F: 09/30/25

A London-based fundamental investor focusing on quality compounders and long-term value creation.

Last 13F: 09/30/25

A diversified hedge fund running systematic and discretionary strategies across equities, credit, and macro.

Last 13F: 09/30/25

A multi-strategy fund blending event-driven, credit, and equity strategies with a focus on special situations.

Last 13F: 09/30/25

A technology-focused private equity firm with public equity investments in software, fintech, and infrastructure.

Last 13F: 09/30/25

A software-focused private equity firm with public equity investments in enterprise technology and SaaS businesses.

Last 13F: 09/30/25

A technology-focused private equity firm investing in software, internet, and technology-enabled businesses.

Last 13F: 09/30/25

A software-focused private equity firm with public equity investments in enterprise software and cybersecurity.

Last 13F: 09/30/25

A Canadian value investor inspired by Buffett's philosophy, seeking compounders with durable moats and patient capital.

Last 13F: 09/30/25

A patient, collaborative activist that builds board relationships and drives long-term operational transformations.

Last 13F: 09/30/25

A London-based quality growth investor running concentrated portfolios in businesses with durable competitive advantages.

Last 13F: 09/30/25

A Minnesota-based value investor focusing on dividend-paying stocks and disciplined long-term capital allocation.

Last 13F: 09/30/25

The investment manager behind Sequoia Fund, running concentrated value portfolios inspired by Buffett's philosophy.

Last 13F: 09/30/25

A value-oriented investor seeking deeply discounted businesses with strong fundamentals and patient capital appreciation.

Last 13F: 09/30/25

A Tiger Cub offshoot running concentrated long/short portfolios in high-quality growth compounders with secular tailwinds.

Last 13F: 09/30/25

A fundamental long/short fund hunting mispriced quality businesses with deep research and patient holding periods.

Last 13F: 09/30/25

A Tiger lineage fund running concentrated, research-heavy portfolios in secular growth themes and quality compounders.

Last 13F: 09/30/25

A concentrated fundamental investor with Tiger DNA, focusing on high-quality growth businesses and secular winners.

Last 13F: 09/30/25

A concentrated software and internet investor running extremely focused portfolios in high-growth technology businesses.

Last 13F: 09/30/25

A fundamental long/short fund blending deep research with concentrated bets in quality businesses and special situations.

Last 13F: 09/30/25

A quantitative hedge fund deploying systematic strategies across equities with a focus on statistical arbitrage and factor investing.

Last 13F: 09/30/25

A global macro and equity fund hunting asymmetric opportunities across geographies and asset classes with discretionary overlays.

Last 13F: 09/30/25

A long-biased fundamental investor running concentrated portfolios in healthcare and special situations with event-driven catalysts.

Last 13F: 09/30/25

A fundamental long/short fund focusing on differentiated research insights and concentrated conviction positions in growth equities.

Last 13F: 09/30/25

A growth-focused long/short fund running concentrated portfolios in technology, healthcare, and consumer secular winners.

Last 13F: 09/30/25

A multi-strategy platform running systematic and discretionary pods across equities, credit, and quantitative strategies.

Last 13F: 09/30/25

A fundamental long/short fund with a technology bias, running concentrated portfolios in high-growth innovation themes.

Last 13F: 09/30/25

A concentrated fundamental investor focusing on differentiated research and long-term compounding in quality businesses.

Last 13F: 09/30/25

A concentrated growth investor seeking businesses with durable competitive advantages and long-term secular tailwinds.

Last 13F: 09/30/25

A fundamental long/short fund focusing on technology and innovation themes with concentrated, research-driven portfolios.

Last 13F: 09/30/25

A growth-focused investor running concentrated portfolios in technology, consumer, and healthcare secular winners.

Last 13F: 09/30/25

A concentrated fundamental investor with a focus on quality compounders and long-term wealth creation through patient capital.

Last 13F: 09/30/25

A fundamental activist investor focusing on operational improvements and strategic value creation in mid-cap businesses.

Last 13F: 09/30/25

A London-based fundamental long/short fund running concentrated portfolios in quality businesses with sustainable advantages.

Last 13F: 09/30/25

A fundamental long/short fund focusing on consumer and technology themes with concentrated, high-conviction portfolios.

Last 13F: 09/30/25

A fundamental long/short fund running concentrated portfolios with deep research in technology and consumer growth themes.

Last 13F: 09/30/25

A fundamental equity manager running concentrated, research-intensive portfolios across sectors with patient capital.

Last 13F: 09/30/25

Stan Druckenmiller's family office running concentrated macro and equity bets with legendary market timing and conviction.

Last 13F: 09/30/25

Carl Icahn's activist vehicle built around concentrated bets, proxy fights, and relentless pressure on underperforming boards.

Last 13F: 09/30/25

Nelson Peltz's activist platform targeting operational improvements and strategic transformations in large-cap businesses.

Last 13F: 09/30/25

A concentrated value investor seeking mispriced businesses with strong fundamentals and patient capital appreciation.

Last 13F: 09/30/25

A Silicon Valley family office managing wealth for tech billionaires, blending private deals with public growth equities.

Last 13F: 09/30/25

Li Lu's concentrated value vehicle hunting asymmetric opportunities in undervalued businesses with durable moats.

Last 13F: 09/30/25

Michael Burry's contrarian value shop famous for betting against consensus and finding deep mispricings in ignored corners.

Last 13F: 09/30/25

Bruce Berkowitz's concentrated value fund seeking deeply discounted businesses with catalysts for value realization.

Last 13F: 09/30/25

A low-turnover value investor focusing on quality compounders with durable franchises and patient capital appreciation.

Last 13F: 09/30/25

A London-based concentrated investor seeking quality businesses with sustainable competitive advantages and long-term growth.

Last 13F: 09/30/25

A Scottish long-term growth investor running patient, concentrated portfolios in secular winners and disruptive innovators.

Last 13F: 09/30/25

A quality-focused investor running ultra-concentrated portfolios in consumer franchises and compounders with pricing power.

Last 13F: 09/30/25

A deep value investor seeking cyclically depressed businesses trading at significant discounts to intrinsic value.

Last 13F: 09/30/25

A contrarian value investor focusing on out-of-favor sectors and mean reversion opportunities in quality businesses.

Last 13F: 09/30/25

An insurance-based investment vehicle running a concentrated equity portfolio alongside underwriting operations in Buffett style.

Last 13F: 09/30/25

Charlie Munger's newspaper-turned-investment vehicle running a concentrated portfolio of quality compounders and banks.

Last 13F: 09/30/25

A biotech powerhouse blending scientific expertise with public and private investments across the life sciences lifecycle.

Last 13F: 09/30/25

A healthcare specialist investing across biotech development stages with deep scientific diligence and catalyst-driven timing.

Last 13F: 09/30/25

A biotech-focused fund with scientific expertise, investing across clinical-stage companies and commercial therapeutics.

Last 13F: 09/30/25

A healthcare investor blending public equities with private venture investments in life sciences and biotech innovation.

Last 13F: 09/30/25

A healthcare specialist focusing on catalyst-driven biotech investments with event-driven timing and scientific research.

Last 13F: 09/30/25

A healthcare giant investing across biotech, pharmaceuticals, and medical devices with deep scientific and financial expertise.

Last 13F: 09/30/25

Paul Tudor Jones' macro powerhouse deploying discretionary and systematic strategies across global markets and asset classes.

Last 13F: 09/30/25

A credit specialist hunting mispricings in distressed debt, special situations, and corporate restructurings with patience.

Last 13F: 09/30/25

A credit and event-driven specialist navigating distressed situations, bankruptcies, and complex capital structures.

Last 13F: 09/30/25

A credit and private equity firm investing across distressed debt, special situations, and operational turnarounds.

Last 13F: 09/30/25

An event-driven credit specialist hunting mispricings in distressed situations, bankruptcies, and corporate restructurings.

Last 13F: 09/30/25

A credit and event-driven specialist navigating structured credit, distressed situations, and special opportunities.

Last 13F: 09/30/25

A systematic macro fund deploying quantitative models across futures, currencies, and global markets with trend-following DNA.

Last 13F: 09/30/25

A global macro fund running discretionary strategies across rates, FX, commodities, and equities with macro overlays.

Last 13F: 09/30/25

A macro powerhouse deploying systematic and discretionary strategies across global rates, FX, and credit markets.

Last 13F: 09/30/25

An event-driven specialist focusing on M&A arbitrage, special situations, and corporate catalyst plays.

Last 13F: 09/30/25

A merger arbitrage specialist hunting spread opportunities in announced M&A deals with disciplined risk management.

Last 13F: 09/30/25

An event-driven fund navigating M&A arbitrage, special situations, and catalyst-rich opportunities with systematic discipline.

Last 13F: 09/30/25

An activist investor targeting operational improvements and strategic alternatives in undervalued businesses.

Last 13F: 09/30/25

An activist powerhouse targeting operational improvements, board changes, and strategic transformations in underperformers.

Last 13F: 09/30/25